secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARROW, INC. (HROW)
CIK:        0001360214
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001493152-23-034832
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harrow Health renames to Harrow, Inc., focusing on eyecare pharmaceuticals
--------------------------------------------------------------------------

- Name change from Harrow Health, Inc. to Harrow, Inc. effective September 29, 2023.
- Reflects exclusive focus on U.S. ophthalmic pharmaceutical market as part of 5-year strategic plan.
- Stockholders not required to approve; rights unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1360214/000149315223034832/0001493152-23-034832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1360214/000149315223034832/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-034832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer